Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats

Neuropsychopharmacology Reports(2020)10.1002/npr2.12139Source: DataRank Database

Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats is a research paper published in Neuropsychopharmacology Reports (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.66)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ryan P. Leman,Thomas Everett,Hendrick Lopez‐Beltran,Lindsey R. Hamilton,Erik B. Oleson ORCID

Live enrichment

PubMed:32935483 PMC:PMC7718284 OpenAlex:https://openalex.org/W3087063189

National Science Foundation

Grant: IOS‐1557755

National Institutes of Health

Grant: R03DA038734

NCI NIH HHS

Grant: P30 CA046934

NIGMS NIH HHS

Grant: T34 GM096958

National Science Foundation

Grant: 1557755

The Role of Transient Striatal Dopamine Release Events in Negative Reinforcement Processes

National Institutes of Health

Grant: 3P30CA046934-20S2

Cancer Center Support Grant

National Institutes of Health

Grant: 1R03DA038734-01A1

Potential Role of Phasic Dopamine and Endocannabinoids in Conditioned Withdrawal

FWCI

0.66

Citation Percentile

0.6%

Citation Trend

2021

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.12139

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/npr2.12139

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12139

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/npr2.12139

journalhttps://doi.org/10.1002/npr2.12139

Fields of Study

Neurotransmitter Receptor Influence on BehaviorNerve injury and regenerationNeuropeptides and Animal Physiology03 medical and health sciences0302 clinical medicineAdministration, IntravenousAnalgesics, OpioidAnimalsBuprenorphineDopamineDopamine AntagonistsDose-Response Relationship, DrugDrug CombinationsHeroinMaleNucleus AccumbensRatsRats, Long-EvansReceptors, Opioid, mu

MeSH Terms

Analgesics, OpioidAnimalsBuprenorphineHeroinDopamineDose-Response Relationship, DrugDrug CombinationsMaleNucleus AccumbensReceptors, Opioid, muDopamine AntagonistsRats, Long-EvansRatsAdministration, Intravenous

Keywords

DopamineHeroinBuprenorphinePharmacologyAnesthesiaOpioidChemistryMedicineInternal medicineDrugVoltammetryAddictionSubstitution TherapyAgonist TherapyMaleReceptors, Opioid, muNeurosciences. Biological psychiatry. NeuropsychiatryRM1-950Nucleus AccumbensAnimalsRats, Long-EvansDose-Response Relationship, DrugOriginal ArticlesRatsAnalgesics, OpioidDrug CombinationsDopamine AntagonistsAdministration, IntravenousTherapeutics. PharmacologyRC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being